For laboratory and research use only. Not for human consumption.
Vesugen 20mg lyophilized vial - US manufactured research peptideCertificate per batchFor laboratory and research use only

The catalog

Vesugen

Tripeptide vascular bioregulator (EDG) studied for proposed effects on endothelial function and cardiovascular tissue aging. Part of Professor Khavinson’s bioregulator series. US-manufactured. ISO 17025 certificate per batch.

Vial formatISO 17025 certificateHPLC purityMass-spec identity

For laboratory and research use only. Not for human consumption.

SourcingAudited U.S. and E.U. facilities. FDA-registered API trail.
IdentityConfirmed by mass spectrometry per batch.
PurityHPLC measured. Printed on the certificate.

FeelGood does not provide dosing guidance, administration instructions, or protocols. Products are supplied for laboratory and research use only and are not intended for human consumption.

The research

What the published literature examined.

Vesugen is a tripeptide vascular bioregulator studied for its proposed role in cardiovascular tissue physiology and blood vessel aging. It is part of Professor Khavinson’s bioregulator series, specifically targeting vascular tissue.

About the Compound

Vesugen is a synthetic tripeptide with the sequence Glutamic acid-Aspartic acid-Glycine (EDG). It is classified as a vascular cytogen, with blood vessel tissue and cardiovascular physiology as its proposed target. Within Khavinson’s bioregulator taxonomy, each peptide corresponds to a specific tissue type; Vesugen is the compound designed to modulate gene expression in vascular cells.

Research has examined Vesugen’s proposed effects on endothelial cell function, vascular wall integrity, and cardiovascular aging markers in animal models. Vascular aging is a primary driver of systemic aging outcomes, which has made this class of bioregulator an area of growing interest in longevity research.

Research Areas

  • Endothelial function. Khavinson group studies have examined effects on endothelial cell gene expression and vascular wall properties in aging models.
  • Cardiovascular aging. Research has investigated proposed effects on age-related vascular changes including arterial stiffness markers in animal models.
  • Cytogen mechanism. The proposed mechanism involves direct interaction with DNA in vascular cells to modulate expression of genes involved in endothelial maintenance.

The research base is primarily from Khavinson’s group. Independent replication is limited. Human clinical data does not exist in published form.

Specifications

  • Compound: Vesugen (EDG)
  • Sequence: Glu-Asp-Gly
  • Molecular weight: 303.25 Da
  • Form: Lyophilized powder, sealed glass vial
  • Size: 20mg
  • Purity: ≥98% by HPLC, batch-verified
  • Identity: Mass spectrometry confirmation per batch
  • Endotoxin: LAL assay per batch, reported on COA
  • Storage: −20°C sealed; 4°C after reconstitution, used within 28 days
  • Manufacturing: United States
  • Testing: Independent ISO 17025-accredited laboratory, batch-specific
  • Shipping: Temperature-controlled with insulated packaging

The Standard

Every batch of FeelGood Vesugen is manufactured in the United States and tested by an independent ISO 17025-accredited laboratory before release. The certificate of analysis specific to your lot ships with the order.

Sold as a research chemical for laboratory and research purposes only. Not intended for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.

Findings summarized in neutral terms based on the published literature. Most of the cited research is preclinical. Sold for research use only.